Results 81 to 90 of about 4,851,513 (185)

The Spectrum of Clinical Symptomatology in Patients with Neuro-Behcet’s Disease

Pakistan Armed Forces Medical Journal, 2022
Objective: To understand the pattern of neurological symptoms in patients diagnosed with Neuro-Behcet's disease. Study Design: Cross-sectional study. Duration and Place of Study: Pak Emirates Military Hospital Rawalpindi, from Jun 2013 to Jun 2018.
Jahanzeb Liaqat, Wasim Wali Muhammad, Saeed Arif, Asif Hashmat, Wasim Alamgir   +4 more
doaj   +2 more sources

Ptosis and Mass Like Lesions in Behçet’s Disease: A Rare Presentation

The Turkish Journal of Gastroenterology, 2018
In this article, we describe a case of neuro-Behçet’s disease presenting with unilateral ptosis and facial paresis due to an intracranial mass lesion. A 25-year-old male patient with a history of Behçet’s disease presented with headache, vertigo, double
Seher KIR, Lütfi AKYOL, Metin ÖZGEN, Hediye PINAR GÜNBEY, Mehmet SAYARLIOĞLU   +4 more
doaj  

Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma Complicating Long‐Standing Immunosuppressed Dermatomyositis

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma (PCGD‐TCL) is a rare cytotoxic lymphoma with key oncogenic drivers in the JAK/STAT pathway. Also primarily involving the subcutaneous adipose tissue, subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is more frequently encountered in scenarios of autoimmune disorders.
Bennett Christie‐Nguyen, Youn H. Kim, David F. Fiorentino, Danielle Tartar, Ryanne Brown, Robert A. Novoa, Kerri E. Rieger   +6 more
wiley   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, Matthias Augustin, Falk G. Bechara, Pierre‐André Becherel, Farida Benhadou, Vincenzo Bettoli, Joana Cabete, Raffaele Dante Caposiena Caro, Antonella Di Cesare, Giovanni Damiani, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Krisztián Gáspár, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Barbara Horvath, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Alexander Katoulis, Natalia Kirsten, Georgios Kokolakis, Piotr K. Krajewski, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Andreas Pinter, Anna Pirogova, Maurizio Podda, Francesca Prignano, Jorge Romani, Marco Romanelli, Elia Rosi, Samed Sahin, Ditte M. L. Saunte, Sylke Schneider‐Burrus, Mariano Suppa, Jacek Szepietowski, Andrea Szegedi, Simon Francis Thomsen, Thrasyvoulos Tzellos, Anastasia Trigoni, Hessel H. Van Der Zee, Kelsey Van Straalen, Skaidra Valiukevičiene, Eva Vilarrasa, Esther von Stebut, Christos C. Zouboulis   +54 more
wiley   +1 more source

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos, Evangelos J. Giamarellos‐Bourboulis, Kelsey R. van Straalen, Antonio Martorell, Brian Kirby, Afsaneh Alavi, Koremasa Hayama, Saakshi Khattri, Wayne Gulliver, Christopher J. Sayed, Leah Davis, Robert L. Rolleri, Christina Crater, Ingrid Pansar, Jérémy Lambert, Christos C. Zouboulis   +15 more
wiley   +1 more source

Seasonal Variation in Flares of Intestinal Behçet's Disease

, 2015
BACKGROUND: There have been numerous investigations into the seasonality of several autoimmune diseases and inflammatory bowel disease in an effort to better understand the epidemiology and pathogenesis of these conditions.
천재희, 김태일, 홍성필, 김원호   +3 more
core   +1 more source

Neurological Behcet’s disease with transverse myelitis in an adolescent: A case report

SAGE Open Medical Case Reports
Neurological Behcet’s disease is a rare systemic vasculitis marked by recurrent oral or genital ulcers, eye manifestations of uveitis or retinal vasculitis, and skin lesions.
Jeanine McColl, Teresa Liang, Dax G. Rumsey   +2 more
doaj   +1 more source

Vision-Threatening Behcet’s Disease: Severity of Ocular Involvement Predictors

Journal of Ophthalmology, 2018
Purpose. To examine and spot systemic findings commonly associated with a serious form of ocular Behcet’s disease. This could potentially help ophthalmologists categorize their patients based on future risk and plan treatment accordingly.
Mohammed A. Hussein, Iman M. Eissa, Ahmed A. Dahab   +2 more
doaj   +1 more source

Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: Relation to clinical course

, 2006
PURPOSE: This study was designed to assess anti-Saccharomyces cerevisiae antibody positive rate in Behçet's disease and intestinal Behçet's disease and to evaluate whether anti-Saccharomyces cerevisiae antibody expression is associated with clinical ...
김태일, 김현숙, 김원호, 이상길   +3 more
core   +1 more source

Alveolar proteinosis in Behçet's disease [PDF]

, 2010
A 51-year-old man with Behçet's disease complained of fever, dry cough and dyspnea during exertion. Chest CT showed ground glass opacities with interstitial septal thickening in both lungs.
Imran Ozdemir, Zuhur Cigdem, Bayar Nihal, Cigdem Zuhur, Seza Tetikkurt, Tetikkurt Seza, Tetikkurt Cuneyt, Ozdemir Imran, Nihal Bayar, Cuneyt Tetikkurt   +9 more
core   +1 more source